These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 6193605)
21. HLA-B POT: a new HLA-antigen within the B7-cross reactive group. Reekers P; van der Beucken M; Andrien M; Beelen J; Mueller-Eckhardt G; Schreuder GM Tissue Antigens; 1986 Sep; 28(3):182-9. PubMed ID: 2431514 [TBL] [Abstract][Full Text] [Related]
22. [2 cases of crossing over in the HLA1 system in 2 siblings of a family]. Gebhardt B; Rönisch P Kinderarztl Prax; 1987 Jan; 55(1):43-6. PubMed ID: 3472013 [No Abstract] [Full Text] [Related]
23. A murine monoclonal antibody specific for a novel broad antigen associated with HLA-Bw4. Wong DM; Mittal KK Tissue Antigens; 1986 Jan; 27(1):10-4. PubMed ID: 2420023 [TBL] [Abstract][Full Text] [Related]
24. [The HLA system and psoriasis: a family study]. Crivellato E; Zacchi T G Ital Dermatol Venereol; 1985; 120(4):247-54. PubMed ID: 3862648 [No Abstract] [Full Text] [Related]
25. The HLA-A:HLA-B crossovers and their contribution in analysing possible haplotype-specific recombination rates. Bender K Hum Genet; 1982; 61(2):127-34. PubMed ID: 6957374 [No Abstract] [Full Text] [Related]
26. HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I. Uno H; Kawano K; Matsuoka H; Tsuda K Clin Exp Immunol; 1988 Feb; 71(2):211-6. PubMed ID: 2894907 [TBL] [Abstract][Full Text] [Related]
28. MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactions. Fainboim L; Jaraquemada D; Festenstein H; Sachs JA Scand J Immunol; 1981 Dec; 14(6):655-67. PubMed ID: 6177031 [TBL] [Abstract][Full Text] [Related]
29. HLA antigens and otosclerosis. A possible new genetic factor. Gregoriadis S; Zervas J; Varletzidis E; Toubis M; Pantazopoulos P; Fessas P Arch Otolaryngol; 1982 Dec; 108(12):769-71. PubMed ID: 6983341 [TBL] [Abstract][Full Text] [Related]
30. [HLA and thyroid cancer]. Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939 [TBL] [Abstract][Full Text] [Related]
31. Intra HLA-D region recombinant maps HLA-DR between HLA-B and HLA-D. Sachs JA; Jaraquemada D; Festenstein H Tissue Antigens; 1981 Jan; 17(1):43-56. PubMed ID: 6454280 [TBL] [Abstract][Full Text] [Related]
32. Type 2 (non-insulin-dependent) diabetes mellitus and HLA antigens in Papua New Guinea. Bhatia K; Patel M; Gorogo M Diabetologia; 1984 Sep; 27(3):370-2. PubMed ID: 6594299 [TBL] [Abstract][Full Text] [Related]
33. HLA-B15 heterogeneity in different populations. Alonso A; Doyle P; Williams E; Gill D; Ollier W; Jaraquemada D; Awad J; Festenstein H Tissue Antigens; 1985 Jan; 25(1):33-7. PubMed ID: 3983950 [No Abstract] [Full Text] [Related]
34. HLA antigens in familial hyper-alphalipoproteinemia. Da Col PG; Soardo G; Zacchi T Tissue Antigens; 1986 Apr; 27(4):244-6. PubMed ID: 3460219 [TBL] [Abstract][Full Text] [Related]
35. The association between congenital adrenal hyperplasia and HLA in Southern Italy. Zappacosta S; Maio M; de Felice M; Valentino R Ann N Y Acad Sci; 1985; 458():46-51. PubMed ID: 3879130 [No Abstract] [Full Text] [Related]
36. [The HLA system and the adult type of cystic kidney]. Mayr WR; Maier U Z Urol Nephrol; 1983; 76(2):75-8. PubMed ID: 6858413 [No Abstract] [Full Text] [Related]
37. Another segregant series, DR, in HLA. Lamm LU Cytogenet Cell Genet; 1978; 22(1-6):309-12. PubMed ID: 88300 [No Abstract] [Full Text] [Related]
39. Public determinants of HLA indicated by pregnancy antibodies. Konoeda Y; Terasaki PI; Wakisaka A; Park MS; Mickey MR Transplantation; 1986 Feb; 41(2):253-9. PubMed ID: 2418552 [TBL] [Abstract][Full Text] [Related]
40. HLA-B14 and nonclassical 21-hydroxylase deficiency in a heterogeneous New York population. Levine LS Ann N Y Acad Sci; 1985; 458():65-70. PubMed ID: 3879132 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]